David Aaron Lehman, General Counsel at Intersect ENT, Inc. (XENT), sold 36,000 shares at $32.75 ($1.2M) on 2017-12-11, disclosed to the SEC on 2017-12-13.
Open-market sale of $1.2M XENT by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LUNG | SELL | 2026-03-04 | $17K | — | Filing → |
| LUNG | SELL | 2025-12-03 | $16K | — | Filing → |
| LUNG | SELL | 2025-09-03 | $16K | — | Filing → |